Industry: Service & Software
Published Date: 2024-07-07
Pages: 170 Pages
Report ld: 3233645
Request Sample
Customized Report
The global Pharmacovigilance Consulting Services market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
The US & Canada market for Pharmacovigilance Consulting Services is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The China market for Pharmacovigilance Consulting Services is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The Europe market for Pharmacovigilance Consulting Services is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key manufacturers of Pharmacovigilance Consulting Services include Eurofins Scientific, Accenture, PPD, SGS, WuXi AppTec, Cognizant, ICON, IQVIA, Parexel, United BioSource, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Pharmacovigilance Consulting Services market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pharmacovigilance Consulting Services, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Pharmacovigilance Consulting Services, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pharmacovigilance Consulting Services revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Pharmacovigilance Consulting Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Pharmacovigilance Consulting Services revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Eurofins Scientific, Accenture, PPD, SGS, WuXi AppTec, Cognizant, ICON, IQVIA, Parexel, United BioSource, etc.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Pharmacovigilance Consulting Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmacovigilance Consulting Services companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmacovigilance Consulting Services revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmacovigilance Consulting Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Writing and Submitting Documents and Reports
1.2.3 Security Database System Services and Data Management
1.2.4 Signal Detection and Evaluation
1.2.5 Training and Consulting
1.2.6 Other
1.3 Market by Application
1.3.1 Global Pharmacovigilance Consulting Services Market Share by Application: 2019 VS 2023 VS 2030
1.3.2 Preclinical
1.3.3 Clinical Phase
1.3.4 Post-launch
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmacovigilance Consulting Services Market Perspective (2019-2030)
2.2 Global Pharmacovigilance Consulting Services Growth Trends by Region
2.2.1 Global Pharmacovigilance Consulting Services Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pharmacovigilance Consulting Services Historic Market Size by Region (2019-2024)
2.2.3 Pharmacovigilance Consulting Services Forecasted Market Size by Region (2025-2030)
2.3 Pharmacovigilance Consulting Services Market Dynamics
2.3.1 Pharmacovigilance Consulting Services Industry Trends
2.3.2 Pharmacovigilance Consulting Services Market Drivers
2.3.3 Pharmacovigilance Consulting Services Market Challenges
2.3.4 Pharmacovigilance Consulting Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Pharmacovigilance Consulting Services by Players
3.1.1 Global Pharmacovigilance Consulting Services Revenue by Players (2019-2024)
3.1.2 Global Pharmacovigilance Consulting Services Revenue Market Share by Players (2019-2024)
3.2 Global Pharmacovigilance Consulting Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Pharmacovigilance Consulting Services, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Pharmacovigilance Consulting Services Market Concentration Ratio
3.4.1 Global Pharmacovigilance Consulting Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacovigilance Consulting Services Revenue in 2023
3.5 Global Key Players of Pharmacovigilance Consulting Services Head office and Area Served
3.6 Global Key Players of Pharmacovigilance Consulting Services, Product and Application
3.7 Global Key Players of Pharmacovigilance Consulting Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmacovigilance Consulting Services Breakdown Data by Type
4.1 Global Pharmacovigilance Consulting Services Historic Market Size by Type (2019-2024)
4.2 Global Pharmacovigilance Consulting Services Forecasted Market Size by Type (2025-2030)
5 Pharmacovigilance Consulting Services Breakdown Data by Application
5.1 Global Pharmacovigilance Consulting Services Historic Market Size by Application (2019-2024)
5.2 Global Pharmacovigilance Consulting Services Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pharmacovigilance Consulting Services Market Size (2019-2030)
6.2 North America Pharmacovigilance Consulting Services Market Size by Type
6.2.1 North America Pharmacovigilance Consulting Services Market Size by Type (2019-2024)
6.2.2 North America Pharmacovigilance Consulting Services Market Size by Type (2025-2030)
6.2.3 North America Pharmacovigilance Consulting Services Market Share by Type (2019-2030)
6.3 North America Pharmacovigilance Consulting Services Market Size by Application
6.3.1 North America Pharmacovigilance Consulting Services Market Size by Application (2019-2024)
6.3.2 North America Pharmacovigilance Consulting Services Market Size by Application (2025-2030)
6.3.3 North America Pharmacovigilance Consulting Services Market Share by Application (2019-2030)
6.4 North America Pharmacovigilance Consulting Services Market Size by Country
6.4.1 North America Pharmacovigilance Consulting Services Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Pharmacovigilance Consulting Services Market Size by Country (2019-2024)
6.4.3 North America Pharmacovigilance Consulting Services Market Share by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Pharmacovigilance Consulting Services Market Size (2019-2030)
7.2 Europe Pharmacovigilance Consulting Services Market Size by Type
7.2.1 Europe Pharmacovigilance Consulting Services Market Size by Type (2019-2024)
7.2.2 Europe Pharmacovigilance Consulting Services Market Size by Type (2025-2030)
7.2.3 Europe Pharmacovigilance Consulting Services Market Share by Type (2019-2030)
7.3 Europe Pharmacovigilance Consulting Services Market Size by Application
7.3.1 Europe Pharmacovigilance Consulting Services Market Size by Application (2019-2024)
7.3.2 Europe Pharmacovigilance Consulting Services Market Size by Application (2025-2030)
7.3.3 Europe Pharmacovigilance Consulting Services Market Share by Application (2019-2030)
7.4 Europe Pharmacovigilance Consulting Services Market Size by Country
7.4.1 Europe Pharmacovigilance Consulting Services Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Pharmacovigilance Consulting Services Market Size by Country (2019-2024)
7.4.3 Europe Pharmacovigilance Consulting Services Market Size by Country (2025-2030)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
7.4.9 Nordic Countries
8 China
8.1 China Pharmacovigilance Consulting Services Market Size (2019-2030)
8.2 China Pharmacovigilance Consulting Services Market Size by Type
8.2.1 China Pharmacovigilance Consulting Services Market Size by Type (2019-2024)
8.2.2 China Pharmacovigilance Consulting Services Market Size by Type (2025-2030)
8.2.3 China Pharmacovigilance Consulting Services Market Share by Type (2019-2030)
8.3 China Pharmacovigilance Consulting Services Market Size by Application
8.3.1 China Pharmacovigilance Consulting Services Market Size by Application (2019-2024)
8.3.2 China Pharmacovigilance Consulting Services Market Size by Application (2025-2030)
8.3.3 China Pharmacovigilance Consulting Services Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Pharmacovigilance Consulting Services Market Size (2019-2030)
9.2 Asia Pharmacovigilance Consulting Services Market Size by Type
9.2.1 Asia Pharmacovigilance Consulting Services Market Size by Type (2019-2024)
9.2.2 Asia Pharmacovigilance Consulting Services Market Size by Type (2025-2030)
9.2.3 Asia Pharmacovigilance Consulting Services Market Share by Type (2019-2030)
9.3 Asia Pharmacovigilance Consulting Services Market Size by Application
9.3.1 Asia Pharmacovigilance Consulting Services Market Size by Application (2019-2024)
9.3.2 Asia Pharmacovigilance Consulting Services Market Size by Application (2025-2030)
9.3.3 Asia Pharmacovigilance Consulting Services Market Share by Application (2019-2030)
9.4 Asia Pharmacovigilance Consulting Services Market Size by Region
9.4.1 Asia Pharmacovigilance Consulting Services Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Pharmacovigilance Consulting Services Market Size by Region (2019-2024)
9.4.3 Asia Pharmacovigilance Consulting Services Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Pharmacovigilance Consulting Services Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Pharmacovigilance Consulting Services Market Size by Type
10.2.1 Middle East, Africa, and Latin America Pharmacovigilance Consulting Services Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Pharmacovigilance Consulting Services Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Pharmacovigilance Consulting Services Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Pharmacovigilance Consulting Services Market Size by Application
10.3.1 Middle East, Africa, and Latin America Pharmacovigilance Consulting Services Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Pharmacovigilance Consulting Services Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Pharmacovigilance Consulting Services Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Pharmacovigilance Consulting Services Market Size by Country
10.4.1 Middle East, Africa, and Latin America Pharmacovigilance Consulting Services Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Pharmacovigilance Consulting Services Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Pharmacovigilance Consulting Services Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Eurofins Scientific
11.1.1 Eurofins Scientific Company Details
11.1.2 Eurofins Scientific Business Overview
11.1.3 Eurofins Scientific Pharmacovigilance Consulting Services Introduction
11.1.4 Eurofins Scientific Revenue in Pharmacovigilance Consulting Services Business (2019-2024)
11.1.5 Eurofins Scientific Recent Development
11.2 Accenture
11.2.1 Accenture Company Details
11.2.2 Accenture Business Overview
11.2.3 Accenture Pharmacovigilance Consulting Services Introduction
11.2.4 Accenture Revenue in Pharmacovigilance Consulting Services Business (2019-2024)
11.2.5 Accenture Recent Development
11.3 PPD
11.3.1 PPD Company Details
11.3.2 PPD Business Overview
11.3.3 PPD Pharmacovigilance Consulting Services Introduction
11.3.4 PPD Revenue in Pharmacovigilance Consulting Services Business (2019-2024)
11.3.5 PPD Recent Development
11.4 SGS
11.4.1 SGS Company Details
11.4.2 SGS Business Overview
11.4.3 SGS Pharmacovigilance Consulting Services Introduction
11.4.4 SGS Revenue in Pharmacovigilance Consulting Services Business (2019-2024)
11.4.5 SGS Recent Development
11.5 WuXi AppTec
11.5.1 WuXi AppTec Company Details
11.5.2 WuXi AppTec Business Overview
11.5.3 WuXi AppTec Pharmacovigilance Consulting Services Introduction
11.5.4 WuXi AppTec Revenue in Pharmacovigilance Consulting Services Business (2019-2024)
11.5.5 WuXi AppTec Recent Development
11.6 Cognizant
11.6.1 Cognizant Company Details
11.6.2 Cognizant Business Overview
11.6.3 Cognizant Pharmacovigilance Consulting Services Introduction
11.6.4 Cognizant Revenue in Pharmacovigilance Consulting Services Business (2019-2024)
11.6.5 Cognizant Recent Development
11.7 ICON
11.7.1 ICON Company Details
11.7.2 ICON Business Overview
11.7.3 ICON Pharmacovigilance Consulting Services Introduction
11.7.4 ICON Revenue in Pharmacovigilance Consulting Services Business (2019-2024)
11.7.5 ICON Recent Development
11.8 IQVIA
11.8.1 IQVIA Company Details
11.8.2 IQVIA Business Overview
11.8.3 IQVIA Pharmacovigilance Consulting Services Introduction
11.8.4 IQVIA Revenue in Pharmacovigilance Consulting Services Business (2019-2024)
11.8.5 IQVIA Recent Development
11.9 Parexel
11.9.1 Parexel Company Details
11.9.2 Parexel Business Overview
11.9.3 Parexel Pharmacovigilance Consulting Services Introduction
11.9.4 Parexel Revenue in Pharmacovigilance Consulting Services Business (2019-2024)
11.9.5 Parexel Recent Development
11.10 United BioSource
11.10.1 United BioSource Company Details
11.10.2 United BioSource Business Overview
11.10.3 United BioSource Pharmacovigilance Consulting Services Introduction
11.10.4 United BioSource Revenue in Pharmacovigilance Consulting Services Business (2019-2024)
11.10.5 United BioSource Recent Development
11.11 Vial
11.11.1 Vial Company Details
11.11.2 Vial Business Overview
11.11.3 Vial Pharmacovigilance Consulting Services Introduction
11.11.4 Vial Revenue in Pharmacovigilance Consulting Services Business (2019-2024)
11.11.5 Vial Recent Development
11.12 Wipro
11.12.1 Wipro Company Details
11.12.2 Wipro Business Overview
11.12.3 Wipro Pharmacovigilance Consulting Services Introduction
11.12.4 Wipro Revenue in Pharmacovigilance Consulting Services Business (2019-2024)
11.12.5 Wipro Recent Development
11.13 PrimeVigilance
11.13.1 PrimeVigilance Company Details
11.13.2 PrimeVigilance Business Overview
11.13.3 PrimeVigilance Pharmacovigilance Consulting Services Introduction
11.13.4 PrimeVigilance Revenue in Pharmacovigilance Consulting Services Business (2019-2024)
11.13.5 PrimeVigilance Recent Development
11.14 Aixial Group
11.14.1 Aixial Group Company Details
11.14.2 Aixial Group Business Overview
11.14.3 Aixial Group Pharmacovigilance Consulting Services Introduction
11.14.4 Aixial Group Revenue in Pharmacovigilance Consulting Services Business (2019-2024)
11.14.5 Aixial Group Recent Development
11.15 TransPerfect
11.15.1 TransPerfect Company Details
11.15.2 TransPerfect Business Overview
11.15.3 TransPerfect Pharmacovigilance Consulting Services Introduction
11.15.4 TransPerfect Revenue in Pharmacovigilance Consulting Services Business (2019-2024)
11.15.5 TransPerfect Recent Development
11.16 ProPharma
11.16.1 ProPharma Company Details
11.16.2 ProPharma Business Overview
11.16.3 ProPharma Pharmacovigilance Consulting Services Introduction
11.16.4 ProPharma Revenue in Pharmacovigilance Consulting Services Business (2019-2024)
11.16.5 ProPharma Recent Development
11.17 HCLTech
11.17.1 HCLTech Company Details
11.17.2 HCLTech Business Overview
11.17.3 HCLTech Pharmacovigilance Consulting Services Introduction
11.17.4 HCLTech Revenue in Pharmacovigilance Consulting Services Business (2019-2024)
11.17.5 HCLTech Recent Development
11.18 QbD Group
11.18.1 QbD Group Company Details
11.18.2 QbD Group Business Overview
11.18.3 QbD Group Pharmacovigilance Consulting Services Introduction
11.18.4 QbD Group Revenue in Pharmacovigilance Consulting Services Business (2019-2024)
11.18.5 QbD Group Recent Development
11.19 Quanticate
11.19.1 Quanticate Company Details
11.19.2 Quanticate Business Overview
11.19.3 Quanticate Pharmacovigilance Consulting Services Introduction
11.19.4 Quanticate Revenue in Pharmacovigilance Consulting Services Business (2019-2024)
11.19.5 Quanticate Recent Development
11.20 Qinecsa Solutions
11.20.1 Qinecsa Solutions Company Details
11.20.2 Qinecsa Solutions Business Overview
11.20.3 Qinecsa Solutions Pharmacovigilance Consulting Services Introduction
11.20.4 Qinecsa Solutions Revenue in Pharmacovigilance Consulting Services Business (2019-2024)
11.20.5 Qinecsa Solutions Recent Development
11.21 Veristat
11.21.1 Veristat Company Details
11.21.2 Veristat Business Overview
11.21.3 Veristat Pharmacovigilance Consulting Services Introduction
11.21.4 Veristat Revenue in Pharmacovigilance Consulting Services Business (2019-2024)
11.21.5 Veristat Recent Development
11.22 Veeda
11.22.1 Veeda Company Details
11.22.2 Veeda Business Overview
11.22.3 Veeda Pharmacovigilance Consulting Services Introduction
11.22.4 Veeda Revenue in Pharmacovigilance Consulting Services Business (2019-2024)
11.22.5 Veeda Recent Development
11.23 Tigermed
11.23.1 Tigermed Company Details
11.23.2 Tigermed Business Overview
11.23.3 Tigermed Pharmacovigilance Consulting Services Introduction
11.23.4 Tigermed Revenue in Pharmacovigilance Consulting Services Business (2019-2024)
11.23.5 Tigermed Recent Development
11.24 Clarivate
11.24.1 Clarivate Company Details
11.24.2 Clarivate Business Overview
11.24.3 Clarivate Pharmacovigilance Consulting Services Introduction
11.24.4 Clarivate Revenue in Pharmacovigilance Consulting Services Business (2019-2024)
11.24.5 Clarivate Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Pharmacovigilance Consulting Services market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 162
USD 4900.00
(Single User License)
The global Pharmacovigilance Consulting Services market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 112
USD 4250.00
(Single User License)
The global market for Pharmacovigilance Consulting Services was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 149
USD 3950.00
(Single User License)
The global Pharmacovigilance Consulting Services market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-14
Pages: 159
USD 2900.00
(Single User License)
The global Pharmacovigilance Consulting Services market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 115
USD 4250.00
(Single User License)
The global Pharmacovigilance Consulting Services market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 168
USD 4900.00
(Single User License)
The global market for Pharmacovigilance Consulting Services was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-11
Pages: 151
USD 3950.00
(Single User License)
The global market for Pharmacovigilance Consulting Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-11
Pages: 110
USD 2900.00
(Single User License)
The global Pharmacovigilance Consulting Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Published Date: 2024-07-07
Pages: 102
USD 2900.00
(Single User License)
The global Pharmacovigilance Consulting Services revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published Date: 2024-07-07
Pages: 136
USD 4350.00
(Single User License)
The global Pharmacovigilance Consulting Services market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 162
The global Pharmacovigilance Consulting Services market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 112
The global market for Pharmacovigilance Consulting Services was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 149
The global Pharmacovigilance Consulting Services market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 159
The global Pharmacovigilance Consulting Services market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 115
The global Pharmacovigilance Consulting Services market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 168
The global market for Pharmacovigilance Consulting Services was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-11
Pages: 151
The global market for Pharmacovigilance Consulting Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-11
Pages: 110
The global Pharmacovigilance Consulting Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Published: 2024-07-07
Pages: 102
The global Pharmacovigilance Consulting Services revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published: 2024-07-07
Pages: 136
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now